Sugi Predict

Sugi Predict / Compounds / SCHEMBL7656115

SCHEMBL7656115

SCHEMBL7656115

C=CCc1cccc(O)c1OP(=O)(Oc1ccccc1)Oc1c(O)cccc1CC=C

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 2/20 0.40
▸ GABRB2 P47870 2/20 0.40
▸ SRC P12931 1/20 0.37
▸ AKR1B1 P15121 1/20 0.35
▸ ANPEP P15144 2/20 0.34
▸ LAP3 P28838 2/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ PTPN1 P18031 1/20 0.33
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL175552 0.80 GABRA1 (0.46) GABRA1GABRB2AKR1B1KDM4EMEN1
SCHEMBL2142447 0.79 KDM4E (0.42) SRCKDM4EALDH1A1
SCHEMBL3801608 0.79 KDM4E (0.42) SRCKDM4EALDH1A1
SCHEMBL7656119 0.78 SRC (0.37) SRCKDM4EMEN1KMT2AMAPT
SCHEMBL8734332 0.75 ELANE (0.39) GABRA1GABRB2SRCMEN1KMT2A
SCHEMBL7656121 0.75 ELANE (0.39) GABRA1GABRB2SRCMEN1KMT2A
SCHEMBL6683898 0.73 CYP3A4 (0.50) SRCANPEPLAP3KDM4EMEN1
SCHEMBL6683620 0.73 CYP3A4 (0.50) SRCANPEPLAP3KDM4EMEN1
Acetic Acid SCHEMBL27937763 0.71 CA1 (0.45) GABRA1GABRB2AKR1B1KDM4EMEN1
SCHEMBL3739900 0.71 GABRA1 (0.50) GABRA1GABRB2AKR1B1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6479688-B2 FROM REACTING TERT-BUTYLHYDROQUINONE AND MONOPHENYL DICHLOROPHOSPHATE IN PRESENCE OF ACID CATALYST; FLAME RETARDANTS AKZO NOBEL NV (NL) 2002-11-12 — — US disclosed
US-6479688-B2 FROM REACTING TERT-BUTYLHYDROQUINONE AND MONOPHENYL DICHLOROPHOSPHATE IN PRESENCE OF ACID CATALYST; FLAME RETARDANTS AKZO NOBEL NV (NL) 2002-11-12 — — US disclosed
US-20020151739-A1 PROCESS FOR MAKING DI(HYDROXYALKYLARYL) ARYL PHOSPHATE COMPOUNDS ICL-IP AMERICA INC. 2002-10-17 — — US disclosed
US-20020151739-A1 PROCESS FOR MAKING DI(HYDROXYALKYLARYL) ARYL PHOSPHATE COMPOUNDS ICL-IP AMERICA INC. 2002-10-17 — — US disclosed
US-6403819-B1 REACTING ORTHO-ALKYL SUBSTITUTED AROMATIC DIOL AND MONOARYL DIHALOPHOSPHATE AKZO NOBEL, NV (NL) 2002-06-11 — — US disclosed
US-6403819-B1 REACTING ORTHO-ALKYL SUBSTITUTED AROMATIC DIOL AND MONOARYL DIHALOPHOSPHATE AKZO NOBEL, NV (NL) 2002-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020151739-A1 PROCESS FOR MAKING DI(HYDROXYALKYLARYL) ARYL PHOSPHATE COMPOUNDS GNPAT, DHODH, DDT GABRA1 3397/4885GABRB2 3463/4885SRC 1254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.